C. Hauswald

Suitability of the dog as an animal model for evaluating theophylline absorption and food effects from different formulations

K. Kowalski, A. Karim, G. Schoenhard, 1990 .

Involvement of cytochrome P-450IIIA in metabolism of potassium canrenoate to an epoxide: mechanism of inhibition of the epoxide formation by spironolactone and its sulfur-containing metabolite.

G. Schoenhard, C. Cook, J. Oppermann, 1993, The Journal of pharmacology and experimental therapeutics.

Difference in metabolic profile of potassium canrenoate and spironolactone in the rat: Mutagenic metabolites unique to potassium canrenoate

P. Finnegan, A. Patel, R. Bible, 2004, Archives of Toxicology.